Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pacemaker Induced Cardiomyopathy: Register for Long-term Response to CRT
DRKS00012342Phase 4Recruiting
- Sponsor
- Medizinisches Schulungszentrum Dr. Volker Leonhardt
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sacubitril + valsartan in heart failure (HF) and Pacemaker-induced cardiomyopathy (PICM), sponsored by Medizinisches Schulungszentrum Dr. Volker Leonhardt. Started Aug 2017; status: recruiting.
02
Drugs
sacubitril + valsartan
03
Conditions
heart failure (HF)Pacemaker-induced cardiomyopathy (PICM)
Beyond the preview
Go deeper on DRKS00012342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00012342.